Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Eric J Belin de Chantemele
Personal Information
Title
Associate Professor
Expertise
Cardiovascular
Institution
Augusta University
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
0
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
PTP1B, a Potential New Therapeutic Target for Diabetic Vascular Complications
Endothelial dysfunction is characterized by a reduced nitric oxide (NO) bioavailability leading to impaired vasodilation and increased inflammation. Loss of endothelial function is a precursor and major contributor to diabetic vascular complications, which are the most disabling and life-threatening complications of diabetes. Despite numerous clinical trials and therapeutic strategies, preventing and managing endothelial function as well as reducing the occurrence of cardiovascular events remains a challenge in diabetic patients. The goal of the present application is to use a novel and clinically relevant approach consisting of combining the use of human saphenous vein and pulmonary arteries, with cultured primary endothelial cells, to identify potential new therapeutic targets for the treatment of diabetic vascular complications. Preliminary data gathered in human saphenous vein and genetically engineered mice identified Protein tyrosine phosphatase 1B (PTP1B) and endoplasmic reticulum (ER) stress as two potential targets. Based on these findings, we hypothesized that increased PTP1B expression in diabetes causes endothelial dysfunction by inducing insulin resistance and ER stress, in endothelial cells. We will test this hypothesis with the two following aims: 1 - To determine whether diabetes induces a dysfunction of the endothelium secondary to increased PTP1B expression and ER stress in human saphenous vein and pulmonary artery endothelial cells, 2 - To determine whether PTP1B deletion or inhibition protects endothelial cells from diabetes-induced dysfunction by improving insulin sensitivity, reducing ER stress and increasing eNOS functioning. We anticipate that these studies will lead to the identification of the molecular mechanisms by which PTP1B regulates endothelial function. We also expect to demonstrate that PTP1B is a potential target for the treatment of diabetic vascular complications.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
PTP1B, a Potential New Therapeutic Target for Diabetic Vascular Complications (Belin de Chantemele, Eric J)
10/27/2015
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Options
No records to display.
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Cardiovascular
The DiaComp Cardiovascular Committee has the principal function of furthering the mission of the consortium with regard to diabetic cardiomyopathy and macrovascular disease.
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!